Illumina Infinium Automated Pipetting System with ILASS

The National Institutes of Health Office of Logistics and Acquisition Operations is procuring an Illumina Infinium Automated Pipetting System with ILASS through a Firm-Fixed-Price Purchase Order (Contract Number 75N98026Q00225). This procurement addresses the NIH's Genomics Core requirement to replace an existing Tecan LiHa automated pipetting robot that is incompatible with Illumina's newly upgraded genotyping platform. The system will support scanning and genotyping services for the National Human Genome Research Institute and NIH-wide investigators utilizing the Illumina iScan system. The government intends to award this contract solely to Illumina, Inc., citing FAR Part 6.302-1 as justification based on Illumina being the only known responsible source capable of meeting the technical requirements. Small businesses in designated categories, including 8(a) firms, service-disabled veteran-owned small businesses, HUBZone small businesses, small disadvantaged businesses, veteran-owned small businesses, and women-owned small businesses, may submit written capability statements by 6:00 a.m. EDT on April 30, 2026, to david.shen@nih.gov to demonstrate their ability to perform the requirement.

This procurement is not utilizing any set-aside designations and represents a single-source award to Illumina, Inc., the incumbent contractor whose platform the Genomics Core currently operates. While no specific award value or budget range is disclosed in the notice, the procurement involves replacement of incompatible equipment with a specialized analytical laboratory instrument classified under NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and PSC 6640 (Laboratory Equipment and Supplies). The notice was posted on April 20, 2026, with a deadline of April 30, 2026, for capability statements and questions. Award is anticipated approximately five days after the notice date, unless the government determines that another vendor can meet the stated requirements.